When the patient has a rapidly growing brain tumor, what slows expansion of cerebral brain tissue into the adjacent hemisphere?

Dexamethasone (Decadron) is a corticosteroid commonly prescribed to clients with expanding brain tumors to reduce cerebral edema. By decreasing swelling and inflammation, it helps relieve intracranial pressure and associated neurological symptoms such as headache or vomiting. Corticosteroids, however, are associated with metabolic and fluid retention side effects that require client education. Monitoring and teaching about weight gain, fluid retention, and hyperglycemia are essential to safe therapy.

Rationale for correct answers:

A. “It is given to reduce swelling of the brain.” Dexamethasone decreases cerebral edema and relieves symptoms of increased ICP. This is the primary therapeutic purpose in brain tumor management.

C. “You may notice weight gain.” Corticosteroids can increase appetite and cause fat redistribution, resulting in weight gain. This is a common, expected side effect of therapy.

E. “It can cause you to retain fluids.” Steroids promote sodium and water retention, which can lead to peripheral edema. Clients should be taught to monitor for swelling or sudden weight changes.

Rationale for incorrect answers:
B. “You will need to monitor for low blood sugar.” Dexamethasone can raise, not lower, blood glucose levels. Hyperglycemia is a more likely concern, especially in clients with diabetes.
D. “Tumor growth will be delayed.” Dexamethasone does not affect tumor growth; it only reduces surrounding edema. Definitive tumor treatment requires surgery, radiation, or chemotherapy.

Take home points

• Dexamethasone reduces cerebral edema but does not shrink the tumor itself.
• Weight gain, fluid retention, and hyperglycemia are key side effects requiring education.
• Client teaching helps ensure early recognition of complications during corticosteroid therapy.

A benign brain tumor is a noncancerous growth that develops only within the brain tissue and does not metastasize to other parts of the body. Unlike malignant tumors, benign tumors grow slowly and remain localized, though they can still cause significant neurological symptoms by compressing brain structures. Educating the client about the localized nature of benign brain tumors helps reduce anxiety and clarify the difference from metastatic disease. Treatment focuses on surgical removal or monitoring rather than systemic therapy.

Rationale for correct answer:
C. “It is limited to brain tissue.” Benign brain tumors do not spread outside the central nervous system. They are localized growths that remain within the brain.

Rationale for incorrect answers:

A. “It can spread to breasts and kidneys.” Benign brain tumors do not metastasize to other organs. This pattern is only seen with malignant or metastatic cancers.

B. “It can develop in your gastrointestinal tract.” Benign brain tumors do not spontaneously appear in other organ systems. Tumors in the GI tract would have a separate origin.

D. “It probably started in another area of your body and spread to your brain.” This describes metastatic brain cancer, not a benign primary brain tumor. Benign tumors originate in the brain itself.

Take home points

• Benign brain tumors remain localized and do not metastasize to other organs.
• They can still cause serious neurological effects by compressing surrounding tissue.
• Patient education reduces anxiety and helps distinguish benign from metastatic disease.